Q3 2025 saw a 22% revenue decline and negative EBITDA due to sales partner underperformance and restructuring, but October showed strong recovery. Strategic divestment and new hires position the company for growth and positive EBITDA in 2026.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.